Skip to main content
Bindu Kanapuru, MD, Hematology, Fairfax, VA, Virginia Hospital Center

BinduKanapuruMD

Hematology Fairfax, VA

Myeloproliferative Disorder Hematology-Oncology

Physician

Are you Dr. Kanapuru?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 43 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Bindu Kanapuru, MD is a hematologist in Fairfax, Virginia. She is currently licensed to practice medicine in Virginia and Maryland. She is affiliated with Inova Fairfax Medical Campus and Virginia Hospital Center.

Education & Training

  • University of Maryland
    University of MarylandFellowship, Hematology and Medical Oncology, 2008 - 2011
  • MedStar Health/Harbor Hospital
    MedStar Health/Harbor HospitalResidency, Internal Medicine, 2004 - 2007
  • Madras Medical College
    Madras Medical CollegeClass of 1996

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2011 - 2024
  • MD State Medical License
    MD State Medical License 2010 - 2012
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Criteria for Selecting Who Can Enroll in Multiple Myeloma Clinical Trials May Exclude Patients from Minority Groups
    Criteria for Selecting Who Can Enroll in Multiple Myeloma Clinical Trials May Exclude Patients from Minority GroupsApril 5th, 2023
  • State of the Science for Multiple Myeloma: Change in the Right Direction
    State of the Science for Multiple Myeloma: Change in the Right DirectionFebruary 14th, 2020
  • How We Should Run Clinical Trials in Myeloma? A Meeting Between Myeloma Experts, Industry and FDA
    How We Should Run Clinical Trials in Myeloma? A Meeting Between Myeloma Experts, Industry and FDAMarch 13th, 2024

Hospital Affiliations